2025 Volume 68 Issue 8 Pages 334-339
The patient was an 81-year-old woman who had been diagnosed with type 2 diabetes at 38 years of age and had been receiving multiple daily insulin injection (MDI) therapy and oral hypoglycemic agents. At the age of 77 years, she lived alone and her HbA1c level deteriorated to 9 %. At 81 years of age, she was hospitalized because her HbA1c level had deteriorated to 10 %. Her insulin secretion decreased, but her self-injection technique was unstable. Therefore, the unit of insulin aspart before meals was fixed to simplify treatment, and the visiting nurse injected semaglutide. However, when a nurse visited her two days after she was discharged from the hospital, it was suspected that she had mistaken her insulin dose. She was readmitted to the hospital with suspected mild cognitive impairment. MDI therapy was judged to be difficult, semaglutide was increased, and insulin aspart was discontinued. Insulin degludec and smart insulin caps were used together and were self-injected. Her family and medical staff could check her insulin records through a smartphone application. For elderly patients with diabetes who live alone, new devices can provide better-quality support.
